PDCD1 and neoplasm: There was a significant reduction of tumor size in combined CIK cells and anti-PD-1-treated mice compared with untreated controls (P<0.001), whereas tumor delay in CIK cells alone-treated mice did not show a significant difference when comparing to controls (P>0.05) (Figure 4A).